Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Content Type
Facet Toggle
Publication Type
Facet Toggle
Article Type
Facet Toggle
Time Frame
Facet Toggle
Nov
16
2023
VIRTUAL
9:00—10:30 AM ET | 2:00 - 3:30 PM GMT
October 13, 2023
The Center for Global Development and Konrad Adenauer Stiftung will bring together policymakers and researchers from the G7, Europe, and Africa to discuss the potential of the Global Gateway (GG) initiative and the Partnership for Global Investment and Infrastructure (PGII) in fulfilling Africa's ne...
Multimedia
September 12, 2023
The first of CGD's conversations with candidates for the presidency of the European Investment Bank was with Margrethe Vestager. Margrethe is the Executive Vice-President of the European Commission and Commissioner for Competition. She has had a long and illustrious political career, having become a...
Jul
20
2023
VIRTUAL
10:00—11:00 AM ET / 3:00-4:00 PM BST
June 14, 2023
Join the Center for Global Development for a virtual panel discussion reflecting on lessons learned from COVAX for future global and regional response efforts to ensure rapid and equitable access to vaccines and other medical countermeasures.
Blog Post
March 07, 2023
The EU and its member states are collectively the world’s largest aid donor, with an annual budget of over $70 billion in 2021. When it comes to global health, however, it has historically punched below its weight. In part, this is due to an internal coordination problem; health is a shared competen...
Mar
7
2023
VIRTUAL
9:30—10:45 AM Eastern Time (US and Canada)
February 27, 2023
Following promising clinical trial results, the first oral antiviral treatments for COVID-19 received emergency use authorization in late 2021. Since then, manufacturers, global health funders, and other partners have focused on ramping up global supply, including via test-and-treat pilot programs. ...
CGD NOTES
December 14, 2022
Almost a year after two oral antiviral treatments received emergency use authorization, demand is extremely low. In this note, we argue that governments and their donor partners should use data and evidence to consider the economic and clinical rationale for registering, financing, purchasing, and d...
Blog Post
December 14, 2022
Four new CGD pieces, released today, examine the current state of play on COVID-19 oral antivirals. Our analyses provide a deep-dive in key cross-cutting areas—demand, voluntary licensing deals for generic supply, and deployment—and offer policy actions for 2023 and beyond.
Blog Post
December 13, 2022
The case for multilateralism could not be clearer. It points to the many global problems that the world faces, which even the most powerful states cannot handle on their own. Containing global pandemics and mitigating climate change are tasks that require global cooperation. And yet, the future of t...